Related Experiment Video
Updated: Jun 10, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Changes to exhaled nitric oxide in asthmatic children after drinking a caffeine-containing cola drink
I Abuzayan1, U Paraskavi, S W Turner
1Child Health, University of Aberdeen, Aberdeen, UK.
Introduction:
Exhaled nitric oxide (FE(NO)) may be a biomarker for airway eosinophilia and of use in the management of childhood asthma. Caffeine ingestion has been associated with changes in FE(NO) concentration in adults. The present study tested the hypothesis that ingestion of a caffeine-containing cola drink will increase FE(NO) in asthmatic children.
Methods:
Exhaled NO was measured in children with asthma before, 30 and 60 min after taking a cola drink containing 0.7 mg/kg caffeine. Intrasubject changes in FE(NO) and flow independent NO parameters were determined including bronchial wall NO flux (J'awNO).
Results:
Eleven children with asthma were recruited, 10 were prescribed inhaled corticosteroids and 9 were skin prick positive. The median [interquartile range, IQR] FE(NO) at baseline was 47 parts per billion [9,64] and this rose to 56 ppb [11, 66] after 30 min and returned to 46 ppb [9, 62] after 60 min, Friedman's test P = 0.003. J'awNO rose from a median [IQR] 2,843 nl/sec [356, 4,247] at baseline to 3,304 nl/sec [479, 4,387] after 30 min and returned to 2,937 nl/sec [356, 4,153] after 60 min, Freidman's test P = 0.003. There was no significant change in other flow independent NO parameters.
Conclusions:
Ingestion of a caffeine-containing cola drink was associated with a modest and transient rise in FE(NO) which is mostly explained by increased NO production in the proximal airways. Ingestion of a caffeine-containing cola drink may result in clinically relevant acute changes in FE(NO) for children with asthma.
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Chemical Factors Affecting Respiration Centers
CO2 has a potent influence on respiration and is strictly regulated. Under...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
